Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Program Overview

This CME program will highlight recent advanced in the management of patients with atopic dermatitis. Adaobi Nwaneshiudu Obasi, MD, PhD will give a comprehensive review of current clinical trial data of therapeutic options for the treatment of atopic dermatitis. Dr. Obasi will also discuss how to develop effective management strategies with the healthcare team to improve outcomes for patients with atopic dermatitis ...
View Course
Screen Shot 2019-03-29 at 10.14.06 AM

Program Overview

This independent CME/CNE lunch symposium, led by Fred D. Lublin, MD, will analyze therapeutic strategies for improving outcomes and reducing disability in patients with multiple sclerosis (MS). The expert faculty will discuss best practices for early detection and monitoring of disease therapy in the MS patient population. The faculty will debate strategies for selecting and switching therapies in ...
View Course
Micrograph of Invasive urothelial carcinoma high grade. Invasive urothelial carcinoma is a type of Transitional cell carcinoma (TCC, also urothelial cell carcinoma or UCC) and is a type of cancer that develops in the urinary system: the kidney, urinary bladder, and accessory organs. It is the most common type of bladder cancer and cancer of the ureter, urethra, and urachus. Invasive urothelial carcinoma originates from tissue lining the inner surface of these hollow organs - transitional epithelium. It can extend from the kidney collecting system to the bladder. H&E Stain

Program Overview

This CME/CNE activity will review recent advances in patients with Bladder Cancer as presented at the American Society of Clinical Oncology- Genitourinary Cancers (ASCO GU) 2019 Symposium in San Francisco, CA. Dr. Richard Lee will inform on clinical decision making for patients with bladder cancer by reviewing the science and tumor microenvironment. He will also discuss the latest clinical treatment ...
View Course
Micrography showing rat liver cancer histology, micrograph, photo under microscope, HE staining

Program Overview

This CME/CNE program will provide learners with an update regarding treatment and management of patients with hepatocellular carcinoma (HCC) through an interactive panel format. The expert faculty will first set the stage for modern day HCC care, reviewing the science, prevalence and current treatment guidelines. Recent clinical trial data of first line, second line and combination therapies will ...
View Course
Micrograh of small cell carcinoma or also know as small cell lung cancer or oat-call carcinoma is a type of highly malignant cancer. PAP Stain

Program Overview

This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC) incorporating data presented at the European Society For Medical Oncology (ESMO) 2018 Conference in Munich, Germany. The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. The faculty will also discuss how ...
View Course
3D Illustration of Human Respiratory System Lungs Anatomy

Program Overview

This CME/CNE program will outline recent advances in the treatment and management of  idiopathic pulmonary fibrosis (IPF), incorporating data presented at the 2018 American College of Chest Physicians (CHEST) Annual Meeting in San Antonio, Texas. Three expert faculty, led by Dr. Fernando Martinez, will review and compare recent guidelines/criteria as it relates to therapeutic decision making in the ...
View Course
Loading...

Upcoming Events

event5
alliance industry summit_event2
event6
nys-rheumatology-spring-meeting_event1
Screen-Shot-2018-12-07-at-8.28.41-AM